Tuesday 3 February 2015

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion



By ANDREW POLLACK via NYT Business Day http://ift.tt/1Dbh8XU

No comments:

Post a Comment